In addition, ApoE ɛ4 carriers exhibit an accelerated breakdown of the blood–brain barrier in the hippocampus and medial temporal lobe, which is linked to cognitive decline independently of Aβ and tau pathology [73]. This evidence concerns the gene MAPT and Mental deterioration.